Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Long-term omeprazole use has been linked in observational studies to modestly higher rates of chronic kidney disease, acute interstitial nephritis, gastric polyps, and possible associations with dementia and stomach cancer, but these studies show correlation rather than proven cause, and major reviews have not confirmed a dementia link. Absolute risk for most people stays low, and the biggest drivers are dose, duration beyond one year, age, and whether an ongoing prescription is still medically necessary. Other considerations include vitamin B12, magnesium, and calcium absorption, bone fracture risk, and rebound acid symptoms when stopping abruptly. There are several important factors and safety steps to weigh before changing anything, so see below to understand more.
If ongoing heartburn, reflux, or stomach pain is the reason you are still taking omeprazole, it is worth clarifying what is actually driving your symptoms rather than staying on a medication indefinitely by default. A free, instant, online symptom check can help you organize your symptoms, flag findings that deserve prompt medical attention, and prepare focused questions so your next conversation with a clinician leads to a clear plan on whether to continue, taper, or investigate further.
Last reviewed for medical accuracy: 09/14/2026
Omeprazole is one of the most commonly prescribed proton-pump inhibitors (PPIs), used to reduce stomach acid in conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome. Like any medication, long-term use can carry risks. Below, we’ll look at three concerns often raised in the medical literature: dementia, kidney disease, and cancer. We’ll summarize what credible studies show, offer practical advice, and help you weigh benefits versus risks without causing unnecessary alarm.
If you experience any of these, speak to your doctor right away—or try a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
Omeprazole is a very effective treatment for acid-related disorders, and for most people, the benefits outweigh potential risks—especially when used appropriately. The concerns about dementia, kidney disease, and cancer come mainly from observational data showing modest associations, not proven causation. By staying on the lowest effective dose, using the medication only as long as needed, and monitoring for symptoms, you can minimize risks.
Always discuss any serious or life-threatening concerns with your healthcare provider. If you’re worried about new symptoms or want to reassess your treatment plan, consider using a trusted online tool like the Ubie Symptom Checker or schedule an in-person visit. Your doctor can help tailor therapy to your individual needs and ensure you get the safest, most effective care.
(References)
* Barnett JL, Robinson M. Optimizing acid-suppression therapy. Manag Care. 2001 Oct;10(10 Suppl):17-21. PMID: 11729443.
* Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031. PMID: 28257716.
* Ford RL, Swanson KA. Proton-Pump Inhibitors and Risk of Dementia. Consult Pharm. 2017 Nov 1;32(11):682-686. doi: 10.4140/TCP.n.2017.682. PMID: 29113635.
* Moayyedi P, Lewis MA. Proton Pump Inhibitors and Dementia: Deciphering the Data. Am J Gastroenterol. 2017 Dec;112(12):1809-1811. doi: 10.1038/ajg.2017.415. PMID: 29215629.
* Pham N, Ludwig MS, Wang M, Ebrahimpour A, Bonnen MD, Diwan AH, Kim SJ, Bryan J, Newton JM, Sikora AG, Donovan DT, Sandulache V, Ghebre YT. Topical Esomeprazole Mitigates Radiation-Induced Dermal Inflammation and Fibrosis. Radiat Res. 2019 Nov;192(5):473-482. doi: 10.1667/RR15398.1. Epub 2019 Aug 15. PMID: 31415221; PMCID: PMC6876297.
* Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020 Dec 22;324(24):2536-2547. doi: 10.1001/jama.2020.21360. PMID: 33351048.
* Chinzon D, Domingues G, Tosetto N, Perrotti M. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arq Gastroenterol. 2022 Apr-Jun;59(2):219-225. doi: 10.1590/S0004-2803.202202000-40. PMID: 35830032.
* Su J, Chen L, Song N, Li X, Huang J, Duan P. Auricular Point-Pressing With Bean Plus Esomeprazole Magnesium in Relieving Gastrointestinal Dysfunction. Altern Ther Health Med. 2022 Nov;28(8):16-22. PMID: 35839117.
* Ou M, Du Z, Lu R, Jiang Y, Zhu H. Causal relationship between proton pump inhibitors and dementia risk: evidence from a Mendelian randomization study. Eur Arch Psychiatry Clin Neurosci. 2025 Dec;275(8):2275-2284. doi: 10.1007/s00406-025-02036-6. Epub 2025 Jun 7. PMID: 40481989.
* Zhang J, An J. Updating understanding of real-world adverse events associated with omeprazole. PLoS One. 2025;20(8):e0330509. doi: 10.1371/journal.pone.0330509. Epub 2025 Aug 20. PMID: 40834017; PMCID: PMC12367145.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.